Inter & Co
INTR
3.60
-0.11
-2.97%
Inter & Co
US · INTR
#2500 by market cap
Listed 2022
3.60
-0.11
-2.97%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
Itau Unibanco Downgrades Inter & Co(INTR.US) to Hold Rating, Raises Target Price to $10Market Newswire · 2025/11/19
-
Rating change
BofA Securities Maintains Inter & Co(INTR.US) With Buy RatingMarket Newswire · 2026/8/7
-
Rating change
Citi Initiates Inter & Co(INTR.US) With Hold Rating, Announces Target Price $6.5Market Newswire · 2026/5/18
-
Rating change
J.P. Morgan Maintains Inter & Co(INTR.US) With Buy Rating, Raises Target Price to $11Market Newswire · 2026/10/6
-
Rating change
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Raises Target Price to $11.5Market Newswire · 2026/5/8
-
Rating change
Analysts Offer Insights on Financial Companies: Ally Financial (ALLY), Inter & Company Incorporation Class A (INTR) and W. R. Berkley Corporation (WRB)TipRanks · 2026/10/21
-
Company notice
Vanguard Intl Fxd Intr (Hdg) ETF: Distribution Tax EstimatesASX · 2026/7/3
-
Rating change
A Quick Look at Today's Ratings for Inter & Co(INTR.US), With a Forecast Between $6 to $11.5Market Newswire · 2026/5/12
-
Company notice
Vanguard Australian Corp Fxd Intr ETF: Distribution Tax EstimatesASX · 2026/7/3
-
Rating change
J.P. Morgan Maintains Inter & Co(INTR.US) With Buy Rating, Cuts Target Price to $9Market Newswire · 2026/5/12
-
Citi Maintains Inter & Co(INTR.US) With Hold Rating, Cuts Target Price to $4Market Newswire · 2026/11/6
-
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Cuts Target Price to $9Market Newswire · 2026/10/29
-
Company notice
Vanguard Australian Corp Fxd Intr ETF: Distribution Tax Estimate VACFASX · 2026/10/5
-
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Cuts Target Price to $10Market Newswire · 2026/10/21
-
Company notice
Vanguard Intl Fxd Intr (Hdg) ETF: Distribution Tax Estimate VIFASX · 2026/10/5
-
Earnings Flash (INTR) Inter&Co Inc. Reports Q3 Revenue $483.0M, Vs. FactSet Est of $532.3MMT Newswires · 2026/11/13
-
Rating change
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Maintains Target Price $11.5Market Newswire · 2026/5/19
-
Company notice
Haizheng Pharmaceutical: Evaluation instructions for the full equity value of all shareholders of Zhejiang Haisheng Pharmaceutical Co., Ltd. involved in capital increase and stock expansion involving Zhejiang Haisheng Pharmaceutical Co., Ltd. plans to intrSZSI · 2018/10/18
-
Rating change
BofA Securities Initiates Inter & Co(INTR.US) With Buy RatingMarket Newswire · 2026/2/19
-
Citi Maintains Inter & Co(INTR.US) With Hold Rating, Cuts Target Price to $6.1Market Newswire · 2026/10/27
-
Rating change
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Raises Target Price to $10Market Newswire · 2025/10/30
-
Rating change
Goldman Sachs Maintains Inter & Co(INTR.US) With Buy Rating, Raises Target Price to $11Market Newswire · 2025/11/15
-
Company notice
Vanguard Intl Fxd Intr (Hdg) ETF: Distribution Tax EstimatesASX · 2026/4/2
-
Company notice
Vanguard Intl Fxd Intr (Hdg) ETF: Distribution Tax EstimatesASX · 2026/1/5
-
Rating change
J.P. Morgan Maintains Inter & Co(INTR.US) With Buy Rating, Cuts Target Price to $7.2Market Newswire · 2024/12/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Inter & Co discussion 0 comments